Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Antares Pharma, Inc.
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

Number of employees : 185 people.
Sales per Business
20192020Delta
Self-administered Parenteral Pharmaceutical Products and Technologies123.86100%149.60100% +20.78%
USD in Million
Sales per region
2020
United States145.7997.5%
Europe3.812.5%
USD in Million
Managers
Name Title Age Since
Robert F. Apple President, Chief Executive Officer & Director 54 2016
Fred M. Powell Chief Financial Officer & Executive Vice President 59 2017
Jonathan S. Jaffe, Dr. Vice President-Clinical & Medical Affairs - -
Peter C. Richardson, Dr. Chief Medical Officer & Executive VP-Research 60 2021
Patrick Madsen Senior Vice President-Operations - 2010
Peter J. Graham Secretary, Chief Compliance Officer & Executive VP 53 -
Thomas J. Garrity Independent Director 71 2003
Anton G. Gueth Independent Director 63 2003
Leonard S. Jacob, Dr. Chairman 71 2008
Robert P. Roche Independent Director 64 2013
Members of the board
Name Title Age Since
Leonard S. Jacob, Dr. Chairman 71 2008
Thomas J. Garrity Independent Director 71 2003
Anton G. Gueth Independent Director 63 2003
Robert F. Apple President, Chief Executive Officer & Director 54 2016
Robert P. Roche Independent Director 64 2013
Peter S. Greenleaf Independent Director 50 2018
Karen Smith Independent Director 52 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 169,967,638 166,313,673 97.9% 0 0.0% 97.9%
Shareholders
NameEquities%
Rubric Capital Management LP 9,500,000 5.59%
The Vanguard Group, Inc. 7,792,779 4.58%
BlackRock Fund Advisors 4,158,350 2.45%
Deerfield Management Company LP 3,983,440 2.34%
Perceptive Advisors LLC 3,745,662 2.20%
Sargent Investment Group LLC 3,596,250 2.12%
SSgA Funds Management, Inc. 3,450,854 2.03%
Centric Wealth Management LLC 3,337,449 1.96%
OrbiMed Advisors Private Equity 3,213,900 1.89%
Geode Capital Management LLC 2,799,516 1.65%
Company contact information
Antares Pharma, Inc.
100 Princeton South
Suite 300
Ewing, NJ 08628

Phone : +1.609.359.3020
Web : http://www.antarespharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Antares Pharma, Inc.
Sector Other Medical Equipment, Supplies & Distribution
Connections : Antares Pharma, Inc.